Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring

NCT04194827 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

267

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DIAGNOSTIC_TEST: Adalimumab serum trough concentration
DIAGNOSTIC_TEST: Disease activity
DRUG: Adalimumab

Sponsor

Reade Rheumatology Research Institute

Collaborators

[object Object]
[object Object]